Sequencing of Chemotherapy and Immunotherapy in Advanced Prostate Cancer Present and Future (2018)
Sequencing of Chemotherapy and Immunotherapy in Advanced Prostate Cancer: Present and Future is the fourth and final in a 4-part series. Topics will include "Role of Chemotherapy and Performance Sta...
1 Marras 201844min
Incorporating New IO Therapies - How to Properly Administer IO Therapies in an Infusion Suite
To improve clinicians’ understanding of current immunotherapeutic agents for the treatment of genitourinary (GU) cancer and to increase their ability to improve patient outcomes and the management of ...
29 Loka 201837min
Immuno-Oncology: A Focus on Bladder Cancer
Immuno-Oncology: A Focus on Bladder Cancer is the second in the 4-part series. Topics will include "non muscle invasive disease" and "muscle invasive disease" as well as "clinical trial evidence" and ...
24 Loka 201854min
AUA2018 Residents Forum: Public Policy and Advocacy in Urology: A Primer for Residents
Speakers: Christopher M. Gonzalez, MD, MBA James M. Dupree, MD, MPH
22 Loka 201817min
Incorporating New IO Therapies - Managing Patient Side Effects
To improve clinicians’ understanding of current immunotherapeutic agents for the treatment of genitourinary (GU) cancer and to increase their ability to improve patient outcomes and the management of ...
19 Loka 201830min
Immuno - Oncoloy: A New Class Of Drugs
Immuno-Oncology: A New Class of Drugs is the first in the 4-part series. Topics will include "Tumor Immunotherapy", "Immunotherapy Drug Availability and Mechanisms of Action", "Vaccines", "Monoclonal ...
10 Loka 201842min
Androgen Axis Agents and Bone Target Therapies in Advanced Prostate Cancer
Androgen Axis Agents and Bone Target Therapies in Advanced Prostate Cancer: What's New is the third podcast in a 4-part series. Topics will include "Manipulating the Androgen Axis: Androgen Biosynthe...
8 Loka 201856min
Incorporating New IO Therapies - Biomarkers
To improve clinicians’ understanding of current immunotherapeutic agents for the treatment of genitourinary (GU) cancer and to increase their ability to improve patient outcomes and the management of ...
4 Loka 201829min
